Terms: = Leukemia AND HOXD13, SPD, 3239, P35453, HOX4I
86 results:
1. The Mechanism of Anti-Tumor Activity of 6-Morpholino- and 6-Amino-9-Sulfonylpurine Derivatives on Human leukemia Cells.
Leventić M; Opačak-Bernardi T; Rastija V; Matić J; Pavlović Saftić D; Ban Ž; Žinić B; Glavaš-Obrovac L
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630388
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic-pharmacodynamic models.
Ibrahim EIK; Karlsson MO; Friberg LE
CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1305-1318. PubMed ID: 37452622
[TBL] [Abstract] [Full Text] [Related]
3. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression.
Kfoury YS; Ji F; Jain E; Mazzola M; Schiroli G; Papazian A; Mercier F; Sykes DB; Kiem A; Randolph M; Calvi LM; Abdel-Wahab O; Sadreyev RI; Scadden DT
Blood Adv; 2023 Nov; 7(21):6608-6623. PubMed ID: 37450380
[TBL] [Abstract] [Full Text] [Related]
4. Serum spd-L1 levels are elevated in patients with viral diseases, bacterial sepsis or in patients with impaired renal function compared to healthy blood donors.
Loacker L; Egger A; Fux V; Bellmann-Weiler R; Weiss G; Griesmacher A; Hoermann G; Ratzinger F; Haslacher H; Schrezenmeier H; Anliker M
Clin Chem Lab Med; 2023 Nov; 61(12):2248-2255. PubMed ID: 37401452
[TBL] [Abstract] [Full Text] [Related]
5. FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation.
Li Y; Yang W; Patel RM; Casey EB; Denby E; Mendoza-Castrejon J; Rodriguez-Lopez P; Magee JA
Blood; 2023 Mar; 141(12):1442-1456. PubMed ID: 36395068
[TBL] [Abstract] [Full Text] [Related]
6. The psychological, psychosocial and emotional wellbeing of children and young people with leukaemia.
Dinsmore E; Rosengarten L
Br J Nurs; 2022 Nov; 31(20):1020-1028. PubMed ID: 36370400
[TBL] [Abstract] [Full Text] [Related]
7. TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
Jiang VC; Hao D; Jain P; Li Y; Cai Q; Yao Y; Nie L; Liu Y; Jin J; Wang W; Lee HH; Che Y; Dai E; Han G; Wang R; Rai K; Futreal A; Flowers C; Wang L; Wang M
Mol Cancer; 2022 Sep; 21(1):185. PubMed ID: 36163179
[TBL] [Abstract] [Full Text] [Related]
8. In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction.
Lu CH; Chung WM; Tsai CH; Cheng JC; Hsu KC; Tzeng HE
Sci Rep; 2022 Jan; 12(1):303. PubMed ID: 34996924
[TBL] [Abstract] [Full Text] [Related]
9. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
[TBL] [Abstract] [Full Text] [Related]
10. The impact of gene-body H3K36me3 patterns on gene expression level changes in chronic myelogenous leukemia.
Zhang LQ; Liu JJ; Liu L; Fan GL; Li YN; Li QZ
Gene; 2021 Nov; 802():145862. PubMed ID: 34352296
[TBL] [Abstract] [Full Text] [Related]
11. Mutant
Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
[TBL] [Abstract] [Full Text] [Related]
12. Soluble programmed cell death protein 1 (spd-1) and the soluble programmed cell death ligands 1 and 2 (spd-L1 and spd-L2) in lymphoid malignancies.
Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
[TBL] [Abstract] [Full Text] [Related]
13. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
14. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-hoxd13 double transgenic mice.
Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
[TBL] [Abstract] [Full Text] [Related]
15. A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.
Yin M; Baslan T; Walker RL; Zhu YJ; Freeland A; Matsukawa T; Sridharan S; Nussenzweig A; Pruitt SC; Lowe SW; Meltzer PS; Aplan PD
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31622281
[TBL] [Abstract] [Full Text] [Related]
16. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.
Askari B; Amiri Rudbari H; Micale N; Schirmeister T; Efferth T; Seo EJ; Bruno G; Schwickert K
Dalton Trans; 2019 Nov; 48(42):15869-15887. PubMed ID: 31620752
[TBL] [Abstract] [Full Text] [Related]
17. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract] [Full Text] [Related]
18. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract] [Full Text] [Related]
19. Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.
Hamadeh L; Enshaei A; Schwab C; Alonso CN; Attarbaschi A; Barbany G; den Boer ML; Boer JM; Braun M; Dalla Pozza L; Elitzur S; Emerenciano M; Fechina L; Felice MS; Fronkova E; Haltrich I; Heyman MM; Horibe K; Imamura T; Jeison M; Kovács G; Kuiper RP; Mlynarski W; Nebral K; Ivanov Öfverholm I; Pastorczak A; Pieters R; Piko H; Pombo-de-Oliveira MS; Rubio P; Strehl S; Stary J; Sutton R; Trka J; Tsaur G; Venn N; Vora A; Yano M; Harrison CJ; Moorman AV;
Blood Adv; 2019 Jan; 3(2):148-157. PubMed ID: 30651283
[TBL] [Abstract] [Full Text] [Related]
20. Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome.
Chung YJ; Khawaja G; Wolcott KM; Aplan PD
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30346380
[TBL] [Abstract] [Full Text] [Related]
[Next]
